Showing results (31-40 of 278) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignanciesMichael C Heinrich, Charles D Blanke, Brian J Druker, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 11, 2003
Ocular side-effects associated with imatinib mesylate (Gleevec)Frederick W Fraunfelder, Jonathan Solomon, Brian J Druker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2003
Practical management of patients with chronic myeloid leukemia receiving imatinibMichael W N Deininger, Stephen G O'Brien, John M Ford, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 13, 2003
No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec/Glivec)Paul La Rosée, Lei Shen, Eric P Stoffregen, et al.
Seminars in Hematology|May 16, 2002
Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxideMichael E O'Dwyer, Paul La Rosée, Ramedivi Nimmanapalli, et al.
Journal of Pediatric Hematology/Oncology|September 15, 2017
Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug ScreensMichelle Degnin, Anupriya Agarwal, Katherine Tarlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemiaThomas O'Hare, Michael W N Deininger, Christopher A Eide, et al.
Pediatric Blood & Cancer|November 1, 2011
In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemiaJason M Glover, Marc Loriaux, Jeffrey W Tyner, et al.
Molecular Cancer Therapeutics|January 7, 2004
Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cellsYoon-Pin Lim, Lang-Shi Diong, Robert Qi, et al.
Cold Spring Harbor Molecular Case Studies|January 26, 2020
Functional characterization of two rare BCR-FGFR1<sup>+</sup> leukemiasEvan J Barnes, Jessica Leonard, Bruno C Medeiros, et al.
Pageof 28